Quick Answer
Emmaus Life Sciences, Inc. reported Total Assets of $21.44 million for the year ending 2025.
- Emmaus Life Sciences, Inc. showed a decrease of -9.2% in Total Assets from 2024 to 2025.
- This data is from Emmaus Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2011 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: $461.8 thousand | Q1 2012: $704.9 thousand | Q1 2013: $882.1 thousand | Q2 2013: $831.3 thousand | Q4 2013: $749.6 thousand | Q1 2014: $924.2 thousand | Q2 2014: $197.3 thousand | Q4 2014: $507.1 thousand | Q2 2015: $273.1 thousand | Q4 2015: $924.3 thousand | Q1 2016: $659.9 thousand | Q2 2016: $706.4 thousand | Q4 2016: $2.47 million | Q1 2017: $2.43 million | Q2 2017: $1.21 million | Q4 2017: $4.54 million | Q1 2018: $4.53 million | Q2 2018: $4.75 million | Q3 2018: $5.15 million | Q1 2019: $71.22 million | Q2 2019: $62.83 million | Q4 2019: $59.46 million | Q1 2020: $65.99 million | Q2 2020: $56.25 million | Q3 2020: $59.94 million | Q1 2021: $62.22 million | Q2 2021: $63.28 million | Q3 2021: $60.06 million | Q1 2022: $51.49 million | Q2 2022: $45.99 million | Q3 2022: $42.20 million | Q1 2023: $48.95 million | Q2 2023: $50.29 million | Q3 2023: $47.45 million | Q1 2024: $29.54 million | Q2 2024: $25.94 million | Q3 2024: $27.34 million | Q1 2025: $22.48 million | Q2 2025: $23.34 million | Q3 2025: $20.76 million.
- Over the full 17 years of available data (2011 to 2025), Emmaus Life Sciences, Inc.'s Total Assets has grown by 5,693.5%.
- Historical annual values: Fiscal year 2025: $21.44 million | Fiscal year 2024: $23.60 million | Fiscal year 2023: $35.18 million | Fiscal year 2022: $48.23 million | Fiscal year 2021: $56.73 million | Fiscal year 2020: $59.54 million | Fiscal year 2019: $59.46 million | Fiscal year 2019: $58.10 million | Fiscal year 2018: $75.28 million | Fiscal year 2018: $5.15 million | Fiscal year 2017: $6.10 million | Fiscal year 2016: $512.1 thousand | Fiscal year 2015: $567.1 thousand | Fiscal year 2014: $1.34 million | Fiscal year 2013: $1.40 million | Fiscal year 2012: $125.3 thousand | Fiscal year 2011: $370.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: